Warren Buffett has been a net seller of stocks in recent months, but it's a different story for Cathie Wood. She's been busy scooping up shares of innovative companies for several of her Ark Invest exchange-traded funds (ETFs). If you're an aggressive investor, here are three stocks that Wood is buying that should be on your list, too.

Wood's flagship Ark Innovation ETF added to its existing position in Beam Therapeutics (NASDAQ: BEAM) over the last several weeks. So did her Ark Genomic Revolution ETF (NYSEMKT: ARKG). 

What does Wood like so much about Beam? The company is a pioneer in the area of base editing, a highly accurate method of editing DNA. Base editing offers several advantages over other types of gene editing, including being more precise and efficient while avoiding unwanted off-target edits. 

Continue reading

Source Fool.com